loader from loading.io

Asthma

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Release Date: 11/28/2022

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation show art Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

The AZALEA–TIMI 71 trial compared abelacimab, a monoclonal antibody targeting factor XI, with rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk. 🚨 New study: Abelacimab vs. Rivaroxaban in AFib 📊 ✅ 62-69% lower bleeding risk than rivaroxaban ✅ 5x lower GI bleeding ⚠️ Slightly higher ischemic stroke rates A promising safer anticoagulant? 🔬 More data needed! #CardioTwitter #CardioEd #MedEd   Abelacimab significantly reduced bleeding compared to rivaroxaban (HR: 0.38 for 150 mg, 0.31 for 90 mg, p<0.001). Gastrointestinal bleeding was five times...

info_outline
Transcatheter Tricuspid Edge-to-Edge Repair is a viable option for severe  Tricuspid Regurgitation show art Transcatheter Tricuspid Edge-to-Edge Repair is a viable option for severe Tricuspid Regurgitation

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

The Tri.Fr Randomized Clinical Trial evaluated the efficacy of Transcatheter Edge-to-Edge Repair (T-TEER) + Optimized Medical Therapy (OMT) versus OMT alone in 300 patients with severe, symptomatic tricuspid regurgitation (TR) across 24 centers in France and Belgium. At 1-year follow-up, 74.1% of patients in the T-TEER group improved, compared to 40.6% in the OMT-alone group (P < .001). T-TEER significantly reduced TR severity, improved NYHA class, patient global assessment (PGA), and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, and had a high procedural success rate (97.3%)...

info_outline
New studies link aircraft noise to serious health risks! 🛩️🔊 show art New studies link aircraft noise to serious health risks! 🛩️🔊

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Three studies examined the health impacts of aircraft noise exposure. The Heathrow Study (2023) found that nighttime aircraft noise increased cardiovascular events, particularly between 22:00–23:00 and 04:30–06:00, likely due to sleep disturbance and stress-related mechanisms. 🚨 New studies link aircraft noise to serious health risks! 🛩️🔊   📌 Nighttime noise boosts heart disease risk 🫀 📌 Increases cognitive decline & dementia risk 🧠 📌 Alters heart structure, raising cardiac event risk 💔   Time for stronger noise regulations! #Health...

info_outline
Fatigue in Air Traffic Control show art Fatigue in Air Traffic Control

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🚨 Air traffic controllers face severe fatigue due to the 2-2-1 shift system, causing sleep loss, cognitive impairment & safety risks. 🛑 FAA & NATCA now plan to replace it with a safer schedule to enhance aviation safety. ✈️ #Fatigue #AviationSafety #ATC   The 2-2-1 shift system in air traffic control (ATC) compresses five shifts into four days, leading to severe fatigue due to counterclockwise rotation and insufficient rest periods. The FAA’s 2024 study found that this schedule causes sleep deprivation, cognitive impairment, and increased safety risks, with 77% of...

info_outline
Continuation vs. Interruption of Oral Anticoagulation during Transcatheter Aortic Valve Implantation (TAVI) show art Continuation vs. Interruption of Oral Anticoagulation during Transcatheter Aortic Valve Implantation (TAVI)

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

The POPular PAUSE TAVI trial investigated whether continuing or interrupting oral anticoagulation during transcatheter aortic valve implantation (TAVI) affected clinical outcomes. The randomized, open-label, noninferiority study included 858 patients and assessed a composite primary outcome of cardiovascular death, stroke, myocardial infarction, major vascular complications, or major bleeding at 30 days. The trial found that continuation was not noninferior to interruption, with higher bleeding risk but no significant difference in thromboembolic events, supporting interruption of...

info_outline
Dr. RR Baliga’s Philosophical Snippets:  Six orthodox Indian schools show art Dr. RR Baliga’s Philosophical Snippets: Six orthodox Indian schools

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

The six orthodox Indian schools of philosophy—Nyaya, Vaisheshika, Samkhya, Yoga, Mimamsa, and Vedanta—offer valuable insights into the mind-body connection, ethics, logic, and holistic well-being.   Understanding these systems can benefit healthcare providers and patients in promoting mental, emotional, and physical health.

info_outline
Transcatheter Aortic Valve Implantation (TAVI) and FFR-Guided PCI vs. Surgical AVR and CABG in Severe Aortic Stenosis with Complex CAD show art Transcatheter Aortic Valve Implantation (TAVI) and FFR-Guided PCI vs. Surgical AVR and CABG in Severe Aortic Stenosis with Complex CAD

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

The TCW Trial compared TAVI + FFR-guided PCI versus SAVR + CABG in patients with severe aortic stenosis and complex coronary artery disease. This multicenter, randomized controlled trial included 172 patients aged ≥70 years. At 1 year, the primary composite endpoint (death, MI, stroke, revascularization, valve reintervention, or major bleeding) was significantly lower in the TAVI + PCI group (4%) compared to SAVR + CABG (23%), meeting both noninferiority and superiority criteria. The study suggests TAVI + PCI as a safer, less invasive alternative with reduced mortality and bleeding...

info_outline
Vascular Access for Cardiac Arrest show art Vascular Access for Cardiac Arrest

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🚑 New studies on #OHCA: No significant survival benefit of intraosseous (IO) over IV access. IV remains the preferred route, with IO as backup. #EmergencyMedicine #CPR #CardiacArrest These 2 randomized clinical trials compared intraosseous (IO) vs. IV vascular access in out-of-hospital cardiac arrest (OHCA). The first study (Denmark) found no significant difference in return of spontaneous circulation (ROSC), 30-day survival, or neurological outcomes between IO and IV access.  The second study (UK) showed slightly higher ROSC in the IV-first group but no survival advantage. Both...

info_outline
Evolocumab shows strong  benefits in older adults (≥75 yrs) show art Evolocumab shows strong benefits in older adults (≥75 yrs)

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🚨 New study: Evolocumab shows strong CV benefits in older adults (≥75 yrs) with ASCVD! 📉 Lower LDL-C, reduced events (HR: 0.79, NNT: 19), & no major safety concerns. Time to rethink lipid guidelines for seniors? 🔬💙 #Cardiology #LipidLowering #Evolocumab

info_outline
Novel Therapeutics for Reduction of Lipoprotein (a) show art Novel Therapeutics for Reduction of Lipoprotein (a)

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

  Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Traditional lipid-lowering therapies have minimal impact on Lp(a), necessitating novel treatments. Zerlasiran, a small-interfering RNA (siRNA), significantly reduces Lp(a) (~85%) by inhibiting hepatic apolipoprotein(a) synthesis via subcutaneous injection. Muvalaplin, an oral small-molecule inhibitor, prevents Lp(a) particle formation, reducing levels by up to 85.8%. Both drugs were well-tolerated in Phase 2 trials, with further studies needed to...

info_outline
 
More Episodes

Dr RR Baliga's Internal Medicine Podcast for Physicians: "GOT KNOWLEDGE DOC" Podcast

This podcast is for physicians and physician extenders

Not medical advice or opinion